Patel D D, Lelli N, Garuti R, Li Volti S, Bertolini S, Knight B L, Calandra S
MRC Lipoprotein Team, Clinical Sciences Centre, Hammersmith Hospital, London, United Kingdom.
J Lipid Res. 1998 Jul;39(7):1466-75.
Two novel mutations of the low density lipoprotein (LDL)-receptor gene were found in two Italian familial hypercholesterolemia (FH)-heterozygotes. The first mutation was an 18 nucleotide duplication in exon 8 which is preceded by an A-->T transversion. The translation product of the mutant allele was predicted to be a receptor with an in-frame insertion of 6 amino acids in repeat B of the epidermal growth factor precursor homology domain. Analysis of LDL-receptor activity in the proband's fibroblasts showed a 50% reduction of 125I-labeled LDL binding and pulse-chase studies suggested that little, if any, of the mutant protein was processed to the mature form. The second mutation was a 7 kb duplication (from intron 2 to intron 6) of exons 3 through 6, predicted to encode an elongated receptor with the duplication of repeats 2-7 of the ligand binding domain. The elongated receptor was processed slightly more slowly than the normal receptor, but was converted to a mature form of the expected size. This mature, mutant receptor was degraded more rapidly than the normal receptor. On ligand blotting the elongated receptor bound twice as much LDL or beta-very low density lipoprotein (betaVLDL) as the normal receptor. In contrast, maximum binding of LDL to proband's cells was decreased to approximately 70% of the normal cells with a significant increase in apparent affinity. Cell association at 37 degrees C, internalization, and degradation showed a similar reduced maximum. Thus these mutations demonstrate that duplications of amino acid sequences in the low density lipoprotein LDL-receptor may disrupt the LDL-receptor pathway at different levels.
在两名意大利家族性高胆固醇血症(FH)杂合子中发现了低密度脂蛋白(LDL)受体基因的两种新突变。第一种突变是外显子8中18个核苷酸的重复,其前有一个A→T颠换。突变等位基因的翻译产物预计是一种受体,在表皮生长因子前体同源结构域的重复序列B中有6个氨基酸的框内插入。对先证者成纤维细胞中LDL受体活性的分析显示,125I标记的LDL结合减少了50%,脉冲追踪研究表明,几乎没有突变蛋白被加工成成熟形式。第二种突变是外显子3至6的7 kb重复(从内含子2到内含子6),预计编码一种延长的受体,其配体结合结构域的重复序列2-7重复。延长的受体加工速度比正常受体略慢,但被转化为预期大小的成熟形式。这种成熟的突变受体比正常受体降解得更快。在配体印迹上,延长的受体结合的LDL或β-极低密度脂蛋白(βVLDL)是正常受体的两倍。相比之下,LDL与先证者细胞的最大结合力降至正常细胞的约70%,表观亲和力显著增加。37℃下的细胞结合、内化和降解显示出类似的最大降低。因此,这些突变表明低密度脂蛋白LDL受体中氨基酸序列的重复可能在不同水平上破坏LDL受体途径。